Диссертация (1174217), страница 28
Текст из файла (страница 28)
Oxytocin and Estrogen Receptor β in the Brain: AnOverview / A. Acevedo-Rodriguez, S.K. Mani, R.J. Handa // Front Endocrinol(Lausanne). – 2015. – N. 6. – P. 160.86. Adamczyk, B. New Insights into the Role of Oxidative Stress Mechanisms in thePathophysiology and Treatment of Multiple Sclerosis / B. Adamczyk, M.Adamczyk-Sowa // Oxid Med Cell Longev. – 2016.
– Vol. 2016. – P. 1973834.87. Ahmed, B. Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary arterydisease in premenopausal women (from the National Heart, Lung, and BloodInstitute sponsored WISEstudy)./ B. Ahmed, C.N. Bairey Merz, B.D. Johnson,[et al.]// Am J Cardiol. – 2008. – Vol.102.
– N. 2. – P. 150-4.88. Aguilar-Rojas, A. The gonadotropin-releasing hormone system: Perspectives fromreproduction to cancer (Review) / A. Aguilar-Rojas, M.A. Pérez-Solis, G. MayaNúñez // Int J Oncol. – 2016. – Vol. 48. – N. 3. – P. 861-868.89. Ali, I. Age and hormone replacement therapy as factors influencing androgen levelsin the postmenopausal female / I.
Ali, T. James, N. Meston, [et al.] //Clin Chem Lab Med. – 2009. – Vol. 47. – N. 2. – P. 202-207.90. Allaway, H.C. The physiology of functional hypothalamic amenorrhea associatedwith energy deficiency in exercising women and in women with anorexia nervosa./H.C. Allaway, E.A. Southmayd, M.J.
De Souza.// Horm Mol Biol Clin Investig. –2016. – Vol. 25. – N. 2. – P. 91-119.17691. Almeida, M. Estrogens and Androgens in Skeletal Physiology and Pathophysiology/ M. Almeida, M.R. Laurent, V. Dubois, [et al.] // Physiol Rev. – 2017. – Vol. 97. –N. 1. – P. 135-187.92. Almey, A.
Estrogen receptors in the central nervous system and their implicationfor dopamine-dependent cognition in females / A. Almey, T.A. Milner, W.G. Brake// Horm Behav. – 2015. – Vol. 74. – P. 125-138.93. Anagnostis P. The effect of hormone replacement therapy and tibolone onlipoprotein (a) concentrations in postmenopausal women: A systematic review andmeta-analysis./ Anagnostis P, Galanis P, Chatzistergiou V, [et al.].// Maturitas.
–2017. – Vol. 99. – P. 27-36.94. Anagnostis, P. Lipoprotein(a) in postmenopausal women: assessment ofcardiovascular risk and therapeutic options./ P. Anagnostis, S. Karras, I.Lambrinoudaki, [et al.] // Int J Clin Pract. – 2016. – Vol. 70. – N.12. – P. 967-977.95. Arafah, B.M. Increased need for thyroxine in women with hypothyroidism duringestrogen therapy / B.M. Arafah // N Engl J Med.
– 2001. – Vol. 344. – N. 23. –P. 1743-1749.96. Arsenadze, N. Heterogenity of the genetic basis of hypogonadotropichypogonadism / N. Arsenadze, A. Loktionova, L. Nefedova [et al.]. // Abstract bookof 16th Congress of European Neuroendocrine Association. - Sofia (Bulgaria),10-13 September 2014. - P. 89 (263).97. Avis, N.E. Midlife Predictors of Health-Related Quality of Life in Older Women /N.E. Avis, A.
Colvin, J.T. Bromberger, R. Hess // J Gerontol A Biol Sci Med Sci. –2018. – Vol. 73. – N. 11. – P. 1574-1580.98. Baber, R.J. 2016 IMS Recommendations on women's midlife health and menopausehormone therapy / R.J. Baber, N. Panay, A. Fenton; IMS Writing Group //Climacteric.
– 2016. – Vol. 19. – N. 2. – P. 109-150.99. Bacchi, E. Low body weight and menstrual dysfunction are common findings inboth elite and amateur ballet dancers / E. Bacchi, G. Spiazzi, G. Zendrini, [et al.] //J Endocrinol Invest. – 2013. – Vol. 36. – N. 5. – P. 343-346.100. Banerjee, A.K.
Patient-Reported Outcome Measures in Safety Event Reporting:PROSPER Consortium guidance / A.K. Banerjee, S. Okun, I.R. Edwards, [et al.];177Patient-Reported Outcomes Safety Event Reporting (PROSPER) Consortium //Drug Saf. – 2013. – Vol. 36. – N. 12.
– P. 1129-1149.101. Beate, K. Genetics of isolated hypogonadotropic hypogonadism: role of GnRHreceptor and other genes / K Beate, N Joseph, R. de Nicolas, K. Wolfram //Int J Endocrinol. – 2012. – Vol. 2012. – P. 147893.102. Bellastella, G. Revisitation of autoimmune hypophysitis: knowledge anduncertainties on pathophysiological and clinical aspects / G.
Bellastella,M.I. Maiorino, A. Bizzarro, [et al.] // Pituitary. – 2016. – Vol. 19. – N. 6. –P. 625-642.103. Beymer, M. The role of kisspeptin and RFRP in the circadian control of femalereproduction. / M. Beymer, J. Henningsen, T. Bahougne, V. Simonneaux // MolCell Endocrinol. – 2016. – Vol. 438.
– P. 89-99.104. Biglia, N. Vasomotor symptoms in menopause: a biomarker of cardiovasculardisease risk and other chronic diseases? / N. Biglia, A. Cagnacci, M. Gambacciani[et al.] // Climacteric. – 2017. – Vol. 20. – N. 4. – P. 306-312.105. Boehm, U. Expert consensus document: European Consensus Statement oncongenitalhypogonadotropichypogonadism--pathogenesis,diagnosisandtreatment.
/ U. Boehm, P.M. Bouloux, M.T. Dattani, [et al.] // Nat Rev Endocrinol.– 2015. – Vol. 11. – N. 9. – P. 547-564.106. Bonomi, M. New understandings of the genetic basis of isolated idiopathic centralhypogonadism. / M. Bonomi, D.V. Libri, F. Guizzardi, [et al.], Idiopathic CentralHypogonadism Study Group of the Italian Societies of Endocrinology and PediatricEndocrinology and Diabetes // Asian J Androl.
– 2012. – Vol. 14. – N. 1. – P. 49-56.107. Börjesson, A.E. The role of estrogen receptor α in the regulation of bone and growthplate cartilage. / A.E. Börjesson, M.K. Lagerquist, S.H. Windahl, C. Ohlsson // CellMol Life Sci. – 2013. – Vol. 70. – N. 21. – P. 4023-4037.108. Bove, R. Hormone therapy use and physical quality of life in postmenopausalwomen with multiple sclerosis. / R. Bove, C.C.
White, K.C. Fitzgerald, [et al.] //Neurology. – 2016. – Vol. 87. – N. 14. – P. 1457-1463.178109. Boyce, B.F. Functions of RANKL/RANK/OPG in bone modeling and remodeling/ B.F. Boyce, L. Xing // Arch Biochem Biophys. – 2008. – Vol. 473. – N. 2. –P. 139-146.110. Broer, S.L. Anti-mullerian hormone predicts menopause: a long-term follow-upstudy in normoovulatory women. / S.L.
Broer, M.J. Eijkemans, G.J. Scheffer,[et al.] // J Clin Endocrinol Metab. – 2011. – Vol. 96. – N. 8. – P. 2532-2539.111. Camille Melón, L. GABAergic regulation of the HPA and HPG axes and the impactof stress on reproductive function. / L. Camille Melón, J. Maguire. //J Steroid Biochem Mol Biol. –2016. – Vol. 160. – P. 196-203.112. Campbell, R.E. Gonadal steroid neuromodulation of developing and maturehypothalamic neuronal networks.
/ R.E. Campbell, A.E. Herbison. //Curr Opin Neurobiol. – 2014. – Vol. 29. – P. 96-102.113. Canonico, M. Hormone therapy and risk of venous thromboembolism amongpostmenopausal women. / M. Canonico. // Maturitas. – 2015. – Vol. 82. – N. 3. –P. 304-307.114. Cano Sokoloff, N. Bone parameters in relation to attitudes and feelings associatedwith disordered eating in oligo-amenorrheic athletes, eumenorrheic athletes, andnonathletes.
/ N. Cano Sokoloff, M.L. Eguiguren, K. Wargo, [et al]. // Int J EatDisord. – 2015. –Vol. 48. – N. 5. – P. 522-6.115. Carmina, E. Increased anti-Mullerian hormone levels and ovarian size in a subgroupof women with functional hypothalamic amenorrhea: further identification of thelink between polycystic ovary syndrome and functional hypothalamic amenorrhea./ E. Carmina, F.
Fruzzetti, R.A. Lobo.// Am J Obstet Gynecol. – 2016. – Vol. 214.– N. 6. – P. 714.e1-6.116. Cedikova M. Multiple roles of mitochondria in aging processes. / M. Cedikova, P.Pitule, M. Kripnerova [et al.] // Physiol. Res. – 2016. – Vol. 65. – Suppl. 5. –P. S519-S531.117. Celik, O. Peptides: Basic determinants of reproductive functions. / O. Celik, S.Aydin, N. Celik, M. Yilmaz // Peptides. – 2015. – Vol. 72. – P. 34-43.179118. Cencioni, C.
Oxidative stress and epigenetic regulation in ageing and age-relateddiseases. / C. Cencioni, F. Spallotta, F. Martelli, [et al.] // Int J Mol Sci. – 2013. –Vol. 14. – N. 9. – P. 17643-17663.119. Chakrabarti, S. Mechanisms of estrogen effects on the endothelium: an overview. /S. Chakrabarti, J.S. Morton, S.T. Davidge // Can J Cardiol.
– 2014. – Vol. 30. –N. 7. – P. 705-712.120. Charnay, P. Human alpha- and beta-globin gene transcription in mouseerythroleukaemia cells. / P. Charnay, R. Treisman, P. Mellon, [et al.] // Philos TransR Soc Lond B Biol Sci. – 1984. – Vol. 307. – P. 261-270.121. Chistiakov, D.A. Mitochondrial aging and age-related dysfunction of mitochondria./ D.A. Chistiakov, I.A. Sobenin, V.V. Revin, [et al.] // Biomed Res Int. – 2014. –Vol. 2014. – P. 238463.122. Clarke S.A.
Kisspeptin across the human lifespan: evidence from animal studies andbeyond. / S.A. Clarke, W.S. Dhillo // J Endocrinol. – 2016. – Vol. 229. – N. 3. –P. 83-98.123. Collins, P. Cardiovascular risk assessment in women - an update. / P. Collins, C.M.Webb, T.J. de Villiers, [et al.] // Climacteric. – 2016. – Vol. 19. – N. 4. – P. 329-336.124.
Cong, Y.I. Actions of human telomerase beyond telomeres. / Y.I. Cong, J.W. Shay// Cell Res. – 2008. – Vol. 18. – N. 7. – P. 725-732.125. Cooper, G.S. Menstrual and reproductive risk factors for ischemic heart disease. /G.S. Cooper, S.A. Ephross, C.R. Weinberg, [et al.] // Epidemiology – 1999.
– N 10.– P. 255–259.126. Cornil, C.A. Rapid control of reproductive behaviour by locally synthesisedoestrogens: focus on aromatase. / C.A. Cornil, A.L. Seredynski, C. de Bournonville,[et. al.] // J Neuroendocrinol. – 2013. – Vol. 25. – N. 11. – P. 1070-1078.127. Counter, C.M. Telomerase activity is restored in human cells by ectopic expressionof hTERT (hEST2), the catalytic subunit of telomerase. / C.M. Counter, M.Meyerson, E.N. Eaton, [et al.] // Oncogene.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
